As of Dec. 3, the CDC has only reported hospitalized EVALI cases and deaths, regardless of hospitalization status.
Six updates:
1. The CDC reported 96 new EVALI cases since Dec. 27, bringing the national case count to 2,602 as of Jan. 7.
2. Fifty-seven people have died from EVALI in 27 states and the District of Columbia. On Jan. 7, the CDC confirmed the nation’s youngest victim killed by vaping-related lung illness to date: a 15-year-old boy from Texas, according to CNN.
3. After a new study found at least one quarter of vaping-related rehospitalizations and deaths occurred within two days of discharge, the CDC now recommends outpatient follow-up within 48 hours.
4. Reported EVALI cases have been declining since September, the CDC reports. After beginning in 2017, vaping-related emergency department visits rose sharply in June 2019.
5. Further evidence has strengthened the suspected link between vitamin E acetate and vaping-related lung illnesses, according to a Dec. 20 study in the New England Journal of Medicine and the CDC.
6. Most EVALI patients report a history of using products containing THC, the CDC says. Overall, 152 different THC-containing product brands were reportedly used by EVALI patients.
More articles on clinical leadership and infection control:
Popular care program doesn’t significantly cut readmission rates, study finds
Another family joins mold-related class-action suit against Seattle Children’s
Insurance status tied to racial disparities in breast cancer diagnosis
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
